STAND. COM. REP. NO.  428

 

Honolulu, Hawaii

                , 2019

 

RE:   H.B. No. 667

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred H.B. No. 667 entitled:

 

"A BILL FOR AN ACT RELATING TO HEALTH,"

 

begs leave to report as follows:

 

     The purpose of this measure, as received by your Committee, is to prohibit pharmacists from accepting prescription drugs for return or exchange once the drug has been dispensed or sold by prescription unless the pharmacist is an authorized collector for the disposal of controlled substances or the prescription drug is recalled.

 

     For the purposes of a public hearing on this measure, your Committee circulated a Proposed H.B. No. 667, H.D. 1 (Proposed Draft), and notified the public that it would be accepting testimony on the Proposed Draft, which allows for the use of either words or figures to indicate quantity on prescriptions where electronic prescriptions are permitted.

 

     The Department of Public Safety and Kaiser Permanente Hawaii supported the Proposed Draft.  The Department of Health provided comments.

 


     Your Committee has adopted the Proposed Draft and amended it further by:

 

     (1)  Changing the effective date to July 1, 2050, to encourage further discussion; and

 

     (2)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 667, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 667, H.D. 1, and be referred to your Committees on Judiciary and Consumer Protection & Commerce.

 

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

JOHN M. MIZUNO, Chair